News
KRYS
153.12
-3.08%
-4.87
Weekly Report: what happened at KRYS last week (0422-0426)?
Weekly Report · 2d ago
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Barchart · 5d ago
UPDATE 2-Abeona shares tumble as FDA declines to approve skin disorder treatment
Abeona Therapeutics shares tumble 51% in after-market trading. U.S. FDA declines to approve its treatment for a rare skin blistering condition. Abeona is seeking approval for the treatment in patients with recessive dystrophic epidermolysis bullosa. Health regulator sought additional data to satisfy requirements.
Reuters · 04/22 20:27
Oversold Conditions For Krystal Biotech (KRYS)
NASDAQ · 04/22 20:19
Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co.
Dow Jones · 04/22 17:58
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target
Benzinga · 04/22 17:48
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 04/22 14:20
Weekly Report: what happened at KRYS last week (0415-0419)?
Weekly Report · 04/22 11:00
KRYSTAL BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF INHALED KB707 FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC SOLID TUMORS OF THE LUNG
Reuters · 04/22 11:00
Krystal Biotech Price Target Raised to $204.00/Share From $178.00 by Stifel
Dow Jones · 04/16 12:33
Stifel Reiterates Buy on Krystal Biotech, Raises Price Target to $204
Benzinga · 04/16 12:22
KRYSTAL BIOTECH INC <KRYS.O>: STIFEL RAISES TARGET PRICE TO $204 FROM $178
Reuters · 04/16 10:42
U.S. RESEARCH ROUNDUP-Advanced Micro Devices, Kroger, Tyson Foods
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Advanced Micro Devices, Kroger and Tyson Foods among companies with new targets. Analysts raise ratings and target prices on several companies. Boeing, Caterpillar and AIG among those with targets raised.
Reuters · 04/16 07:18
Weekly Report: what happened at KRYS last week (0408-0412)?
Weekly Report · 04/15 10:53
Krystal Biotech Reaches Analyst Target Price
NASDAQ · 04/09 13:18
Weekly Report: what happened at KRYS last week (0401-0405)?
Weekly Report · 04/08 10:57
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
Krystal Biotech, Inc. Will be presenting new preclinical data on local and systemic immune activation following intratumoral injection of the Company’s platform technology at the American Association for Cancer Research 2024 Annual Meeting in San Diego, 2024. The Company is a commercial-stage biotechnology company.
Barchart · 04/04 06:00
Weekly Report: what happened at KRYS last week (0325-0329)?
Weekly Report · 04/01 10:55
KRYSTAL BIOTECH INC <KRYS.O>: EVERCORE ISI RAISES TARGET PRICE TO $201 FROM $168
Reuters · 04/01 05:51
Weekly Report: what happened at KRYS last week (0318-0322)?
Weekly Report · 03/25 10:58
More
Webull provides a variety of real-time KRYS stock news. You can receive the latest news about Krystal Biotech through multiple platforms. This information may help you make smarter investment decisions.
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. It is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include VYJUVEK, KB407, KB408, KB707, KB105, KB104, KB104, and KB301. Its commercial product VYJUVEK is a non-invasive, topical, redo sable gene therapy designed to deliver two copies of theCOL7A1 gene when applied directly to DEB wounds. VYJUVEK is designed to treat DEB at the molecular level by providing the patient’s skin cells the template to make normal COL7 protein, thereby addressing the fundamental disease-causing mechanism. KB407 is developed for the treatment of Cystic Fibrosis. KB408 is developed for the treatment of Alpha-1 Antitrypsin Deficiency. KB707 is developed for the treatment of solid tumors. KB105 is developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis.